Triple-negative breast cancer: Neoadjuvant durvalumab improves prognosis

被引：0
|
作者：
Kunzell, Judith Lorenz
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
D O I：
10.1055/a-1985-2104
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Eine vielversprechende Therapiestrategie beim fruhen Mammakarzinom ist die Gabe von Immuncheckpoint-Inhibitoren zusatzlich zur neoadjuvanten Chemotherapie. Die GeparNuevo-Studie prufte bei Frauen mit einem triple-negativen Tumor den PD-L1-(Programmed Death-Ligand 1-)Inhibitor Durvalumab zusatzlich zur anthrazyklin-/taxanbasierten Zytostase gegen Placebo. Nun liegen die Ergebnisse zu den sekundaren uberlebensendpunkten vor.
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials
    Amos, Keith D.
    Adamo, Barbara
    Anders, Carey K.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012
  • [32] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [33] Novel Neoadjuvant Treatment Strategies for Triple-Negative Breast Cancer
    Davis, Andrew A.
    Gradishar, William J.
    ONCOLOGY-NEW YORK, 2020, 34 (05): : 176 - +
  • [34] Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer
    Yang, Qiuhui
    Fu, Yeqin
    Wang, Jiaxuan
    Yang, Hongjian
    Zhang, Xiping
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2023, 24 (12): : 1123 - 1140
  • [35] Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
    Cserni, Gabor
    Quinn, Cecily M.
    Foschini, Maria Pia
    Bianchi, Simonetta
    Callagy, Grace
    Chmielik, Ewa
    Decker, Thomas
    Fend, Falko
    Kovacs, Aniko
    van Diest, Paul J.
    Ellis, Ian O.
    Rakha, Emad
    Tot, Tibor
    CANCERS, 2021, 13 (22)
  • [36] Influence of hormonal factors on triple-negative breast cancer prognosis
    Weymuller, V.
    Caille, A.
    Diguisto, C.
    Chas, M.
    Jourdan, M. L.
    Arbion, F.
    Body, G.
    Ouldamer, L.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2019, 47 (05): : 471 - 477
  • [37] Pathologic method for extracting good prognosis group in triple-negative breast cancer after neoadjuvant chemotherapy
    Eguchi, Yuki
    Nakai, Tokiko
    Kojima, Motohiro
    Wakabayashi, Masashi
    Sakamoto, Naoya
    Sakashita, Shingo
    Miyazaki, Saori
    Taki, Tetsuro
    Watanabe, Reiko
    Watanuki, Rurina
    Yamauchi, Chisako
    Iwatani, Tsuguo
    Mukohara, Toru
    Onishi, Tatsuya
    Ishii, Genichiro
    CANCER SCIENCE, 2022, 113 (04) : 1507 - 1518
  • [38] Comparison of the effectiveness of neoadjuvant chemotherapy and adjuvant chemotherapy for improving prognosis in triple-negative breast cancer patients
    Li, Wangbin
    Chang, Yuwei
    Bai, Xiaohui
    Cao, Hongxin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (08): : 3978 - 3989
  • [39] Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer
    Bae, Soo Youn
    Lee, Jeong Hyeon
    Bae, Jeoung Won
    Jung, Seung Pil
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2020, 98 (06) : 291 - 298
  • [40] Correlation of serum NLR, PLR and HALP with efficacy of neoadjuvant chemotherapy and prognosis of triple-negative breast cancer
    Lou, Caiyu
    Jin, Fenyuan
    Zhao, Qiang
    Qi, Hongming
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (05): : 3240 - 3246
12345